{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:03:09Z","timestamp":1783699389840,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":59,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.curtheres.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T13:46:54Z","timestamp":1491313614000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial"],"prefix":"10.1016","volume":"84","author":[{"given":"Takeo","family":"Odaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2017.03.007_bib1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00535-009-0047-5","article-title":"Epidemiology and clinical characteristics of GERD in the Japanese population","volume":"44","author":"Fujiwara","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/nmo.12319","article-title":"Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy","volume":"26","author":"Suzuki","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.curtheres.2017.03.007_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11894-008-0045-4","article-title":"Potential adverse effects of proton pump inhibitors","volume":"10","author":"Cot\u00e9","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.curtheres.2017.03.007_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2165\/00003495-200767110-00001","article-title":"Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure","volume":"67","author":"Fass","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.curtheres.2017.03.007_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton pump inhibitor failure in gastro-oesophageal reflux disease. Where next?","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.03.007_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2036.2008.03596.x","article-title":"The influence of comorbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease","volume":"27","author":"Nojkov","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.03.007_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00535-009-0070-6","article-title":"Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring","volume":"44","author":"Iwakiri","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.curtheres.2017.03.007_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00535-013-0788-z","article-title":"Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application","volume":"48","author":"Tominaga","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.1993.tb00120.x","article-title":"Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients","volume":"7","author":"Tatsuta","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.03.007_bib12","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2169\/internalmedicine.49.3803","article-title":"Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia","volume":"49","author":"Kusunoki","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.curtheres.2017.03.007_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00535-011-0488-5","article-title":"Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan","volume":"47","author":"Tominaga","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00535-013-0896-9","article-title":"A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study","volume":"49","author":"Tominaga","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2008.03863.x","article-title":"Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux","volume":"29","author":"Conchillo","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.03.007_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/nmo.12500","article-title":"Normative values in esophageal high-resolution manometry","volume":"27","author":"Herregods","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.curtheres.2017.03.007_bib17","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MCG.0b013e3182557099","article-title":"Interobserver variability in esophageal body measurements with high-resolution manometry among new physician users","volume":"47","author":"Singh","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.curtheres.2017.03.007_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1442-2050.2007.00747.x","article-title":"Multichannel intraluminal impedance and esophageal manometry data for unrestricted swallowing: establishing normal values","volume":"21","author":"Wilson","year":"2008","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.curtheres.2017.03.007_bib19","series-title":"Esophageal motility and pH testing technique and interpretation","author":"Castell","year":"2000"},{"key":"10.1016\/j.curtheres.2017.03.007_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000356222","article-title":"The role of gastroesophageal reflux in relation to symptom onset in patients with proton pump inhibitor-refractory nonerosive reflux disease accompanied by an underlying esophageal motor disorder","volume":"89","author":"Izawa","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.curtheres.2017.03.007_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2036.2010.04517.x","article-title":"Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study","volume":"33","author":"Miwa","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2017.03.007_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5056\/jnm.2012.18.2.181","article-title":"Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux","volume":"18","author":"Morita","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.curtheres.2017.03.007_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5056\/jnm.2010.16.2.148","article-title":"Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria","volume":"16","author":"Noh","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.curtheres.2017.03.007_bib24","doi-asserted-by":"crossref","first-page":"G42","DOI":"10.1152\/ajpgi.00462.2011","article-title":"Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease","volume":"303","author":"Nahata","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X1730019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X1730019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T19:59:12Z","timestamp":1535918352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X1730019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"alternative-id":["S0011393X1730019X"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2017.03.007","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}